LONDON, April 17, 2018 /PRNewswire/ --
Report Details
The neuromodulation devices market is estimated to grow at a CAGR of 11.7% in the first half of the forecast period. The Spinal Cord Stimulation (SCS) submarket is estimated to account for 43.6% share of this market in 2018.
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 221-page report you will receive 125 charts- all unavailable elsewhere.
The 221-page report provides clear detailed insight into the global neuromodulation devices market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Neuromodulation Devices market forecasts from 2018-2028
• This report also breaks down the revenue forecast for the global neuromodulation devices market by type: • Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS) • Vagus Nerve Stimulation (VNS) • Sacral Nerve Stimulation (SNS) • Gastric Electrical Stimulation (GES) • Other Applications
This report discusses the market trends and lists the leading products/pipeline products of each submarket.
• This report provides individual revenue forecasts to 2028 for these regional and national markets: • North America: the US and Canada • Europe: France, Germany, Italy, U.K, Spain, Russia, Rest of Europe • Asia-Pacific: Japan, China, India, Australia, South Korea and rest of Asia-Pacific • Latin America: Brazil, Mexico, Rest of Latin America • Rest of the World: Middle East, Africa
Each regional market is further segmented by type of applications: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications
• Our study gives qualitative analysis of the neuromodulation devices market. It discusses the factors that drive and restrain the neuromodulation devices market. This study also provides a SWOT and STEP analysis.
• Our study discusses the selected leading companies that are the major players in the neuromodulation devices industry: • Medtronic • Boston Scientific • St Jude Medical (Abbott) • Cyberonics (LivaNova) • Stryker Corporation • Nevro Corp. • SetPoint Medical • Functional Neuromodulation • Neurotherapies Reset • Wringless Implantable Stretchable Electronics (WISE) • SceneRay • Mindray
Visiongain's study is intended for anyone requiring commercial analyses for the global neuromodulation devices market. You find data, trends and predictions.
Buy our report today Global Neuromodulation Devices Report 2018-2028: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications.
To request a report overview of this report, please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100
Or click on: https://www.visiongain.com/Report/2165/Global-Neuromodulation-Devices-Report-2018-2028
List of Companies Mentioned in the Report
Abbott
Accellent
Advanced Uro-Solutions
Aleva Neurotherapeutics
Atrotech
Autonomic Technologies
Avery Biomedical
Axonics Modulation
Bard Electrophysiology
Bayer AG
BioControl Medical
Bioness, Inc.
BlueWind
Boston Scientific
CardioMEMS
Cerbomed GmbH
CerebralRx
CerebroMed
Cogentix Medical
Covidien
CVRx, Inc
Cyberonics
DBI
Deep Brain Innovations
electroCore
EndoNovo
EndoStim Inc
Enopace Biomedical
EnteroMedics
Functional Neuromodulation
Genesys Capital
Greatbatch
Halo Neuroscience
ImThera Medical
ImThera Medical, Inc.
InCube Labs
Integer Holdings Corporation
IoGyn, Inc.
Laborie Medical Technologies
Lake Region Medical
LivaNova
MagStim
MainStay Medical
Medtronic
Medtronic Eindhoven Design Centre (MEDC)
Medtronic International Trading Sarl
MedtronicNeuro
MetaCure
Metavention
Microtransponder
Mindray
Nanostim
NDI Medical
NeuImpulse
NeuroPace
NeuroSigma
NeuroStar
Neurotherapies Reset
NeuroTherm
NeuroVista Corp
NeuSpera
Nevro
Newronika
Nexstim plc
nUro Inc
Nuvectra Corporation
QiG Group,LLC
Rio Grande
Sapiens SBS
Sapiens Steering Brain Stimulation
SceneRay
Scion NeuroStim
SetPoint Medical
Sorin
SorinSpA
Soterix Medical
Spinal Modulation Inc
SPR Therapeutics
St. Jude Medical
StarMedTec
StimGuard, LLC.
Stimwave
Stryker Corporation
Synapse Medical
Urolplasty
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain
Advertisement
Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications
Advertisement
Report Details
The neuromodulation devices market is estimated to grow at a CAGR of 11.7% in the first half of the forecast period. The Spinal Cord Stimulation (SCS) submarket is estimated to account for 43.6% share of this market in 2018.
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 221-page report you will receive 125 charts- all unavailable elsewhere.
The 221-page report provides clear detailed insight into the global neuromodulation devices market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Neuromodulation Devices market forecasts from 2018-2028
• This report also breaks down the revenue forecast for the global neuromodulation devices market by type: • Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS) • Vagus Nerve Stimulation (VNS) • Sacral Nerve Stimulation (SNS) • Gastric Electrical Stimulation (GES) • Other Applications
This report discusses the market trends and lists the leading products/pipeline products of each submarket.
• This report provides individual revenue forecasts to 2028 for these regional and national markets: • North America: the US and Canada • Europe: France, Germany, Italy, U.K, Spain, Russia, Rest of Europe • Asia-Pacific: Japan, China, India, Australia, South Korea and rest of Asia-Pacific • Latin America: Brazil, Mexico, Rest of Latin America • Rest of the World: Middle East, Africa
Each regional market is further segmented by type of applications: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications
• Our study gives qualitative analysis of the neuromodulation devices market. It discusses the factors that drive and restrain the neuromodulation devices market. This study also provides a SWOT and STEP analysis.
• Our study discusses the selected leading companies that are the major players in the neuromodulation devices industry: • Medtronic • Boston Scientific • St Jude Medical (Abbott) • Cyberonics (LivaNova) • Stryker Corporation • Nevro Corp. • SetPoint Medical • Functional Neuromodulation • Neurotherapies Reset • Wringless Implantable Stretchable Electronics (WISE) • SceneRay • Mindray
Visiongain's study is intended for anyone requiring commercial analyses for the global neuromodulation devices market. You find data, trends and predictions.
Buy our report today Global Neuromodulation Devices Report 2018-2028: Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), Other Applications.
To request a report overview of this report, please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100
Or click on: https://www.visiongain.com/Report/2165/Global-Neuromodulation-Devices-Report-2018-2028
List of Companies Mentioned in the Report
Abbott
Accellent
Advanced Uro-Solutions
Aleva Neurotherapeutics
Atrotech
Autonomic Technologies
Avery Biomedical
Axonics Modulation
Bard Electrophysiology
Bayer AG
BioControl Medical
Bioness, Inc.
BlueWind
Boston Scientific
CardioMEMS
Cerbomed GmbH
CerebralRx
CerebroMed
Cogentix Medical
Covidien
CVRx, Inc
Cyberonics
DBI
Deep Brain Innovations
electroCore
EndoNovo
EndoStim Inc
Enopace Biomedical
EnteroMedics
Functional Neuromodulation
Genesys Capital
Greatbatch
Halo Neuroscience
ImThera Medical
ImThera Medical, Inc.
InCube Labs
Integer Holdings Corporation
IoGyn, Inc.
Laborie Medical Technologies
Lake Region Medical
LivaNova
MagStim
MainStay Medical
Medtronic
Medtronic Eindhoven Design Centre (MEDC)
Medtronic International Trading Sarl
MedtronicNeuro
MetaCure
Metavention
Microtransponder
Mindray
Nanostim
NDI Medical
NeuImpulse
NeuroPace
NeuroSigma
NeuroStar
Neurotherapies Reset
NeuroTherm
NeuroVista Corp
NeuSpera
Nevro
Newronika
Nexstim plc
nUro Inc
Nuvectra Corporation
QiG Group,LLC
Rio Grande
Sapiens SBS
Sapiens Steering Brain Stimulation
SceneRay
Scion NeuroStim
SetPoint Medical
Sorin
SorinSpA
Soterix Medical
Spinal Modulation Inc
SPR Therapeutics
St. Jude Medical
StarMedTec
StimGuard, LLC.
Stimwave
Stryker Corporation
Synapse Medical
Urolplasty
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain
